| The Joy Of Speech & Language Llc | |
|
550 Brookside Ave, Allendale, NJ 07401-1812 | |
| (201) 327-6732 | |
| Not Available |
| Full Name | The Joy Of Speech & Language Llc |
|---|---|
| Type | Facility |
| Speciality | Speech-language Pathologist |
| Location | 550 Brookside Ave, Allendale, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972262970 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| The Joy Of Speech & Language Llc 550 Brookside Ave, Allendale, NJ 07401-1812 Ph: (201) 327-6732 | The Joy Of Speech & Language Llc 550 Brookside Ave, Allendale, NJ 07401-1812 Ph: (201) 327-6732 |
News Archive
Researchers at the Hebrew University of Jerusalem, in collaboration with researchers at the Salk Institute in California, have found for the first time that a specific protein is essential not only for maintaining a healthy retina in the eye, but also may have implications for understanding and possibly treating other conditions in the immune, reproductive, vascular and nervous systems, as well as in various cancers.
An American Thoracic Society-led international task force has released a guidance document to help guide clinicians on restoring elective in-person pulmonary and sleep services as COVID-19 incidence decreases in their communities.
Medications do not have a chance to fight health problems if they are taken improperly or not taken at all. Non-adherence to medications costs thousands of lives and billions of dollars each year in the United States alone, according to the New England Healthcare Institute. Now, researchers at the University of Missouri have developed an intervention strategy that is three times more effective than previously studied techniques at improving adherence in patients.
Adamas Pharmaceuticals, Inc., a privately held company, announced today the results from the first clinical study evaluating triple combination antiviral drug (TCAD) therapy for the treatment of influenza A in immunocompromised patients. Data from this Phase 1b study were presented by clinical investigator Dr. Janet Englund in a clinical symposium at the 23rd International Conference on Antiviral Research (ICAR) in San Francisco.
The World Health Assembly, bringing the 192 Member States of the World Health Organization together, is set to consider several critical health issues next week.
› Verified 4 days ago
Marissa Manzi, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 31 Cedar Dr, Allendale, NJ 07401 Phone: 201-575-1119 | |
Joy Lisa Hollander-fink, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 550 Brookside Ave, Allendale, NJ 07401 Phone: 201-326-6732 Fax: 201-327-6732 | |
Lauren Hegyi, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 22 Harreton Rd, Allendale, NJ 07401 Phone: 201-887-7731 |